Completed
Phase 2
All Genders
ID00000246
Rapid Benzodiazepine Detoxification Using Flumazenil
Led by Yale University · Updated on 2016-09-08
10
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
CONDITIONS
Brief Title
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Who Can Participate
All Genders
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here